Ultromics raises $55M Series C to scale AI-driven heart failure detection, enhancing diagnostics for HFpEF and cardiac amyloidosis.
Amount Raised
$55 Million
Round Type
Series C
OxfordshireBiotechnologyHealth CareInvestors
Description
Oxford-based Ultromics, a pioneer in AI-driven cardiology diagnostics solutions, has raised $55 million through its Series C funding round. The funding will be used to scale their EchoGo® platform, designed to improve detection of complex heart conditions. Ultromics addresses significant diagnostic challenges in heart failure detection. Their AI technology aids clinicians in identifying high-risk patients earlier, integrating smoothly into existing workflows.
Quick answer
Ultromics raised $55 Million in a Series C round, dated July 31, 2025. Investors: Blue Venture Fund, GV, Lightrock and Allegis Capital. Ultromics is based in Oxfordshire, England, United Kingdom.
- How much did Ultromics raise?
- Ultromics raised $55 Million in a Series C round on July 31, 2025.
- Who invested in Ultromics?
- Blue Venture Fund, GV, Lightrock and Allegis Capital are named as investors in this round.
- What does Ultromics do?
- Ultromics pioneers precision heart failure detection.
- Where is Ultromics based and how big is it?
- Ultromics is based in Oxfordshire, England, United Kingdom. Fundz records about 69 employees.
- Who are the decision-makers at Ultromics?
- Fundz holds 1 contact at Ultromics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology and Health Care around the same time
Companies in the same sectors as Ultromics that raised within 45 days of this round, from Fundz verified event records.
- OpenHealth Technologies raised $3M (Seed) on September 11, 2025.
- Sophont raised $9.2M (Seed) on September 11, 2025.
- Talphera, Inc. raised $17M on September 10, 2025.
- CUTISS raised $68M (Series C) on September 10, 2025.
- Epigenic Therapeutics raised $60M (Funding Round) on September 9, 2025.
- iRegene Therapeutics raised an undisclosed amount (Series B) on September 9, 2025.
Who to call at Ultromics, and when
A new round usually means Ultromics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Ultromics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Ultromics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Ultromics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Ultromics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Ultromics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.